[HTML][HTML] Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases

YY Wu, HC Kuo - Journal of Biomedical Science, 2020 - Springer
Recent transcriptome analyses have revealed that noncoding RNAs (ncRNAs) are broadly
expressed in mammalian cells and abundant in the CNS, with tissue and cell type-specific …

[HTML][HTML] Role of prenatal hypoxia in brain development, cognitive functions, and neurodegeneration

NN Nalivaeva, AJ Turner, IA Zhuravin - Frontiers in neuroscience, 2018 - frontiersin.org
This review focuses on the role of prenatal hypoxia in the development of brain functions in
the postnatal period and subsequent increased risk of neurodegenerative disorders in later …

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

J Täubel, W Hauke, S Rump, J Viereck… - European heart …, 2021 - academic.oup.com
Abstract Aims Cardiac microRNA-132-3p (miR-132) levels are increased in patients with
heart failure (HF) and mechanistically drive cardiac remodelling processes. CDR132L, a …

[HTML][HTML] Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer's disease

H Walgrave, S Balusu, S Snoeck, EV Eynden… - Cell Stem Cell, 2021 - cell.com
Neural stem cells residing in the hippocampal neurogenic niche sustain lifelong
neurogenesis in the adult brain. Adult hippocampal neurogenesis (AHN) is functionally …

Current and emerging avenues for Alzheimer's disease drug targets

R Loera‐Valencia, A Cedazo‐Minguez… - Journal of internal …, 2019 - Wiley Online Library
Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a
global epidemic, and so far, there is neither cure nor treatment to alter its progression. The …

[HTML][HTML] Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

KS Sheinerman, JB Toledo, VG Tsivinsky… - Alzheimer's research & …, 2017 - Springer
Background Minimally invasive specific biomarkers of neurodegenerative diseases (NDs)
would facilitate patient selection and disease progression monitoring. We describe the …

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease

NM Abdelmaksoud, AAM Sallam, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Alzheimer's disease (AD) is a multifaceted, advancing neurodegenerative illness that is
responsible for most cases of neurological impairment and dementia in the aged population …

Circular HDAC9/microRNA-138/Sirtuin-1 pathway mediates synaptic and amyloid precursor protein processing deficits in Alzheimer's disease

Y Lu, L Tan, X Wang - Neuroscience bulletin, 2019 - Springer
Synaptic dysfunction and abnormal processing of amyloid precursor protein (APP) are early
pathological features in Alzheimer's disease (AD). Recently, non-coding RNAs such as …

[HTML][HTML] The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

H Walgrave, L Zhou, B De Strooper, E Salta - Molecular …, 2021 - Springer
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …

[HTML][HTML] Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing

LD Nguyen, Z Wei, MC Silva, S Barberán-Soler… - Nature …, 2023 - nature.com
MicroRNAs (miRNAs) regulate fundamental biological processes by silencing mRNA targets
and are dysregulated in many diseases. Therefore, miRNA replacement or inhibition can be …